A medical worker prepares a dose of vaccine for nasal introduction, that has been developed by Gamalei Research Institute of Epidemiology and Microbiology, in the University clinical hospital No 2 of the First Moscow State Medical University named after I. Sechenov in Moscow, Russia.

11.02.2022#8111157

A volunteer of the clinical trial of Sputnik V (Gam-COVID-Vac) vaccine for nasal introduction, that has been developed by Gamalei Research Institute of Epidemiology and Microbiology, undergoes a medical check-up before receiving a doze of the vaccine in the University clinical hospital No 2 of the First Moscow State Medical University named after I. Sechenov in Moscow, Russia.

11.02.2022#8111144

A volunteer of the clinical trial of Sputnik V (Gam-COVID-Vac) vaccine for nasal introduction, that has been developed by Gamalei Research Institute of Epidemiology and Microbiology, undergoes a medical check-up before receiving a dose of the vaccine in the University clinical hospital No 2 of the First Moscow State Medical University named after I. Sechenov in Moscow, Russia.

11.02.2022#8111138

A volunteer of the clinical trial of Sputnik V (Gam-COVID-Vac) vaccine for nasal introduction, that has been developed by Gamalei Research Institute of Epidemiology and Microbiology, donates blood before receiving a dose of the vaccine in the University clinical hospital No 2 of the First Moscow State Medical University named after I. Sechenov in Moscow, Russia.

11.02.2022#8111133

A volunteer of the clinical trial of Sputnik V (Gam-COVID-Vac) vaccine for nasal introduction, that has been developed by Gamalei Research Institute of Epidemiology and Microbiology, undergoes a medical check-up before receiving a dose of the vaccine in the University clinical hospital No 2 of the First Moscow State Medical University named after I. Sechenov in Moscow, Russia.

11.02.2022#8111130

A volunteer of the clinical trial of Sputnik V (Gam-COVID-Vac) vaccine for nasal introduction, that has been developed by Gamalei Research Institute of Epidemiology and Microbiology, receives a doze of the vaccine in the University clinical hospital No 2 of the First Moscow State Medical University named after I. Sechenov in Moscow, Russia.

11.02.2022#8111123

A volunteer of the clinical trial of Sputnik V (Gam-COVID-Vac) vaccine for nasal introduction that has been developed by Gamalei Research Institute of Epidemiology and Microbiology, is pictured in the University clinical hospital No 2 of the First Moscow State Medical University named after I. Sechenov in Moscow, Russia.

11.02.2022#8111116

A solution of Sputnik V (Gam-COVID-Vac) vaccine for nasal introduction that has been developed by Gamalei Research Institute of Epidemiology and Microbiology, is pictured in the University clinical hospital No 2 of the First Moscow State Medical University named after I. Sechenov in Moscow, Russia.

11.02.2022#8111109

A solution of Sputnik V (Gam-COVID-Vac) vaccine for nasal introduction that has been developed by Gamalei Research Institute of Epidemiology and Microbiology, is pictured in the University clinical hospital No 2 of the First Moscow State Medical University named after I. Sechenov in Moscow, Russia.

11.02.2022#8111107

A solution of Sputnik V (Gam-COVID-Vac) vaccine for nasal introduction that has been developed by Gamalei Research Institute of Epidemiology and Microbiology, is pictured in the University clinical hospital No 2 of the First Moscow State Medical University named after I. Sechenov in Moscow, Russia.

11.02.2022#8111104